These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. The role of non-HLA single nucleotide polymorphisms in multiple sclerosis susceptibility. Bahreini SA; Jabalameli MR; Saadatnia M; Zahednasab H J Neuroimmunol; 2010 Dec; 229(1-2):5-15. PubMed ID: 20832869 [TBL] [Abstract][Full Text] [Related]
6. Heterogeneity at the HLA-DRB1 locus and risk for multiple sclerosis. Barcellos LF; Sawcer S; Ramsay PP; Baranzini SE; Thomson G; Briggs F; Cree BC; Begovich AB; Villoslada P; Montalban X; Uccelli A; Savettieri G; Lincoln RR; DeLoa C; Haines JL; Pericak-Vance MA; Compston A; Hauser SL; Oksenberg JR Hum Mol Genet; 2006 Sep; 15(18):2813-24. PubMed ID: 16905561 [TBL] [Abstract][Full Text] [Related]
7. Influence of HLA-DRB1 allele heterogeneity on disease risk and clinical course in a West Australian MS cohort: a high-resolution genotyping study. Wu JS; James I; Wei Qiu ; Castley A; Christiansen FT; Carroll WM; Mastaglia FL; Kermode AG Mult Scler; 2010 May; 16(5):526-32. PubMed ID: 20207784 [TBL] [Abstract][Full Text] [Related]
8. Replication of top markers of a genome-wide association study in multiple sclerosis in Spain. Cavanillas ML; Fernández O; Comabella M; Alcina A; Fedetz M; Izquierdo G; Lucas M; Cénit MC; Arroyo R; Vandenbroeck K; Alloza I; García-Barcina M; Antigüedad A; Leyva L; Gómez CL; Olascoaga J; Otaegui D; Blanco Y; Saiz A; Montalbán X; Matesanz F; Urcelay E Genes Immun; 2011 Mar; 12(2):110-5. PubMed ID: 20944657 [TBL] [Abstract][Full Text] [Related]
9. Protective role of the HLA-A*02 allele in Portuguese patients with multiple sclerosis. Silva AM; Bettencourt A; Pereira C; Santos E; Carvalho C; Mendonça D; Costa PP; Monteiro L; Martins B Mult Scler; 2009 Jun; 15(6):771-4. PubMed ID: 19482867 [TBL] [Abstract][Full Text] [Related]
10. Association to the Glypican-5 gene in multiple sclerosis. Lorentzen AR; Melum E; Ellinghaus E; Smestad C; Mero IL; Aarseth JH; Myhr KM; Celius EG; Lie BA; Karlsen TH; Franke A; Harbo HF J Neuroimmunol; 2010 Sep; 226(1-2):194-7. PubMed ID: 20692050 [TBL] [Abstract][Full Text] [Related]
11. A genome screen for linkage disequilibrium in HLA-DRB1*15-positive Germans with multiple sclerosis based on 4666 microsatellite markers. Goedde R; Sawcer S; Boehringer S; Miterski B; Sindern E; Haupts M; Schimrigk S; Compston A; Epplen JT Hum Genet; 2002 Sep; 111(3):270-7. PubMed ID: 12215840 [TBL] [Abstract][Full Text] [Related]
12. HLA-DRB1*1501, -DQB1*0301, -DQB1*0302, -DQB1*0602, and -DQB1*0603 alleles are associated with more severe disease outcome on MRI in patients with multiple sclerosis. Zivadinov R; Uxa L; Bratina A; Bosco A; Srinivasaraghavan B; Minagar A; Ukmar M; Benedetto Sy; Zorzon M Int Rev Neurobiol; 2007; 79():521-35. PubMed ID: 17531857 [TBL] [Abstract][Full Text] [Related]
16. Genetics for understanding and predicting clinical progression in multiple sclerosis. Depaz R; Granger B; Cournu-Rebeix I; Bouafia A; Fontaine B Rev Neurol (Paris); 2011 Nov; 167(11):791-801. PubMed ID: 21683424 [TBL] [Abstract][Full Text] [Related]
17. Smoking and two human leukocyte antigen genes interact to increase the risk for multiple sclerosis. Hedström AK; Sundqvist E; Bäärnhielm M; Nordin N; Hillert J; Kockum I; Olsson T; Alfredsson L Brain; 2011 Mar; 134(Pt 3):653-64. PubMed ID: 21303861 [TBL] [Abstract][Full Text] [Related]
18. The role of HLA-DRB1 alleles on susceptibility and outcome of a Portuguese Multiple Sclerosis population. Silva AM; Pereira C; Bettencourt A; Carvalho C; Couto AR; Leite MI; Marta M; Freijo M; Costa PP; Mendonça D; Monteiro L; Armas JB; Martins B J Neurol Sci; 2007 Jul; 258(1-2):69-74. PubMed ID: 17412364 [TBL] [Abstract][Full Text] [Related]
19. The genetics of multiple sclerosis. Lin R; Charlesworth J; van der Mei I; Taylor BV Pract Neurol; 2012 Oct; 12(5):279-88. PubMed ID: 22976058 [TBL] [Abstract][Full Text] [Related]
20. Two HLA class I genes independently associated with multiple sclerosis. Link J; Lorentzen AR; Kockum I; Duvefelt K; Lie BA; Celius EG; Harbo HF; Hillert J; Brynedal B J Neuroimmunol; 2010 Sep; 226(1-2):172-6. PubMed ID: 20678810 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]